StockWatch
·
Biotechnology: Pharmaceutical Preparations
Management ChangeMay 19, 2026, 04:56 PM

Cingulate Directors Ervin & Roberts Depart; Board Size Reduced to 5

AI Summary

Cingulate Inc. announced that Class II directors Jeff Ervin and Jay Roberts will not seek re-election at the 2026 Annual Meeting of Stockholders, as the company aims to reduce its Board size to five directors. The Board also intends to appoint a new chairman. Additionally, Jeff Hargroves resigned as a Class I director and was immediately re-appointed as a Class II director to ensure proper class balance, and he has been nominated for election at the upcoming Annual Meeting.

Key Highlights

  • Jeff Ervin and Jay Roberts will not seek re-election as Class II directors.
  • Cingulate's Board intends to reduce its size to five (5) directors.
  • The Board plans to appoint a new chairman.
  • Jeff Hargroves resigned as a Class I director and was immediately re-appointed as a Class II director.
  • Mr. Hargroves was nominated to stand for election at the 2026 Annual Meeting.
  • The Class I directors now consist of Peter Werth and Frederick Jiang.